Your browser doesn't support javascript.
loading
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.
Ortiz, Michael V; Ahmed, Saima; Burns, Melissa; Henssen, Anton G; Hollmann, Travis J; MacArthur, Ian; Gunasekera, Shehana; Gaewsky, Lyvia; Bradwin, Gary; Ryan, Jeremy; Letai, Anthony; He, Ying; Naranjo, Arlene; Chi, Yueh-Yun; LaQuaglia, Michael; Heaton, Todd; Cifani, Paolo; Dome, Jeffrey S; Gadd, Samantha; Perlman, Elizabeth; Mullen, Elizabeth; Steen, Hanno; Kentsis, Alex.
Afiliação
  • Ortiz MV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Ahmed S; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Burns M; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Henssen AG; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Hollmann TJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • MacArthur I; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Gunasekera S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Gaewsky L; Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Bradwin G; Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Ryan J; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Letai A; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • He Y; Children's Oncology Group Statistics and Data Center, Department of Biostatistics, University of Florida, Gainesville, Florida, USA.
  • Naranjo A; Children's Oncology Group Statistics and Data Center, Department of Biostatistics, University of Florida, Gainesville, Florida, USA.
  • Chi YY; Children's Oncology Group Statistics and Data Center, Department of Biostatistics, University of Florida, Gainesville, Florida, USA.
  • LaQuaglia M; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Heaton T; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Cifani P; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Dome JS; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Gadd S; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Perlman E; Center for Cancer and Blood Disorders, Children's National Health System, Washington, DC, USA.
  • Mullen E; Department of Pathology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Steen H; Department of Pathology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Kentsis A; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
JCI Insight ; 4(15)2019 08 08.
Article em En | MEDLINE | ID: mdl-31391345

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Biomarcadores Tumorais / Tumor de Wilms / Neoplasias Renais / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JCI Insight Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Biomarcadores Tumorais / Tumor de Wilms / Neoplasias Renais / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JCI Insight Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos